Colon cancer continues to be one of the leading causes of cancer-related deaths worldwide, with poor dietary habits ...
A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra ...
Depo-Provera, a widely used injectable type of contraceptive, has played a significant role in reproductive healthcare ...
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
Threats of federal funding cuts are already felt within research circles at UNC, including the labs of some leading cancer ...
A paper in the Journal of the National Cancer Institute finds that almost 20% of patients in middle-stage cancer drug trials ...
The FDA has granted priority review to the new drug application for zongertinib to treat adults with unresectable or metastatic, HER2-mutant NSCLC who have received prior systemic therapy.